Ohio Couple Welcomes Baby from 31-Year-Old Frozen Embryo
By
The Onion Staff
A five-star bake. Worth schmearing, sharing, saving.
Summary
An Ohio couple has welcomed a baby born from an embryo frozen for over 31 years, marking the longest known storage time before a successful birth. This milestone highlights advancements in reproductive technology and raises ethical and scientific questions about long-term embryo preservation.
Key quotes
· 3 pulledAn Ohio couple gave birth to a baby developed from an embryo that had been frozen for more than 30 years.
This appears to be the longest storage time before a birth.
The milestone raises ethical and scientific questions about long-term embryo preservation.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·1h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·1h ago
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
bbc.co.uk·5h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h ago